Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the effectiveness and safety of risperidone for behavioral disturbances in dementia patients and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia
• Vascular Dementia

Drugs mentioned

• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Janssen Pharmaceutica N.V., Belgium | Conditions: Dementia, Alzheimer Disease | Phase 3 | Status: COMPLETED